Xencor to Present at 2014 Leerink Global Healthcare Conference Read more about Xencor to Present at 2014 Leerink Global Healthcare Conference
Xencor, Inc. Announces Closing of Initial Public Offering Read more about Xencor, Inc. Announces Closing of Initial Public Offering
Xencor Receives Advanced Technology Program Grant For Safer Protein Therapeutics Read more about Xencor Receives Advanced Technology Program Grant For Safer Protein Therapeutics
Xencor Co-Founder, Stephen Mayo, Presents Protein Design Automation Results at AAAS Meeting Read more about Xencor Co-Founder, Stephen Mayo, Presents Protein Design Automation Results at AAAS Meeting
Xencor Receives SBIR Phase II Grant for High Throughput Screening of Novel Computationally Derived Optimized Proteins Read more about Xencor Receives SBIR Phase II Grant for High Throughput Screening of Novel Computationally Derived Optimized Proteins
Xencor Expands Management Team; Leverages $50 Million Series C Financing to Fuel Development Efforts Read more about Xencor Expands Management Team; Leverages $50 Million Series C Financing to Fuel Development Efforts
Xencor Receives Two Patents For Ultra-Fast Optimization Technology To Create A New Generation Of Biotechnology Products Read more about Xencor Receives Two Patents For Ultra-Fast Optimization Technology To Create A New Generation Of Biotechnology Products
